Intuitive Surgical Inc. (NASDAQ:ISRG) stock fell more than 11% in Friday premarket trading after the robotic surgery company reported second-quarter results that topped Wall Street estimates but reaffirmed its procedure growth outlook.
The company maintained its 2026 da Vinci procedure growth forecast but warned that changes in insurance coverage, including the expiration of enhanced Affordable Care Act premium subsidies, modestly slowed U.S. procedure growth in the second quarter.
The comments contrasted with recent optimism from Abbott Laboratories (NYSE:ABT) and followed HCA Healthcare Inc.’s (NYSE:HCA) warning of softer surgical demand, according to Reuters.
During the earnings call, CEO David Rosa said, “In our customer conversations, some have said changes in patient coverage and premium dynamics may be affecting when patients seek care and move forward with treatment.”
Read Next
